Venture Capital News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Venture CapitalNewsTandemAI Closes $22M Series A Extension Round
TandemAI Closes $22M Series A Extension Round
Venture Capital

TandemAI Closes $22M Series A Extension Round

•November 14, 2025
0
FinSMEs
FinSMEs•Nov 14, 2025

Companies Mentioned

TandemAI

TandemAI

GoodRx

GoodRx

Pfizer

Pfizer

PFE

Cursor

Cursor

Parallel Web Systems

Parallel Web Systems

Novo Holdings

Novo Holdings

Open.Video

Open.Video

Why It Matters

The infusion of $22 million highlights strong market confidence in AI‑powered drug discovery, potentially speeding up candidate identification and giving TandemAI a competitive edge in a rapidly evolving biotech landscape.

TandemAI Closes $22M Series A Extension Round

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...